Citation: Jg. Slatter et al., Pharmacokinetics, metabolism, and excretion of irinotecan (CPT-11) following i.v. infusion of [C-14]CPT-11 in cancer patients, DRUG META D, 28(4), 2000, pp. 423-433
Citation: Pd. Cunha et al., Immune hemolytic anemia caused by sensitivity to a metabolite of etodolac,a nonsteroidal anti-inflammatory drug, TRANSFUSION, 40(6), 2000, pp. 663-668